- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- NAG- MAN- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lorig-Roach, N. et al., Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab. Sci Rep (2024)
- Release Date
- 2023-12-06
- Peptides
- Lirilumab Fab Heavy Chain: A
Lirilumab Fab Light chain: B
Killer cell immunoglobulin-like receptor 2DL3: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HB
LC
A